Ameritas Investment Company’s Exelixis EXEL Stock Holding History

Ameritas Investment Company’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-304	Closed	-$6K	–	1242
2018 Q4	$6K	Buy	+304	New	+$5.42K	﹤0.01%	1171

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Ameritas Investment Company's EXEL Position: Q1 2019 in Review

Ameritas Investment Company sold out of Exelixis (EXEL) in Q1 2019, closing a stake of 304 shares — an estimated $6K sold.

Ameritas Investment Company first reported a position in EXEL in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 378 funds tracked by Wall St. Rank hold EXEL as of Q1 2019.

Ameritas Investment Company reported no remaining Exelixis position as of Q1 2019 after selling out during the quarter.
Ameritas Investment Company sold 304 Exelixis shares in Q1 2019, an estimated $6K.
Ameritas Investment Company first reported a position in Exelixis in Q4 2018 and held it in 1 quarter.
Ameritas Investment Company's Exelixis position peaked at $6K in Q4 2018.
378 funds tracked by Wall St. Rank held Exelixis as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.